H Kiran; G Kiran; Ekerbiçer, Hasan Çetin; Am Guven; M Kilinc
(BLACKWELL PUBLISHING, 2004)
Conclusions: The data from the present study suggest that intranasal administration of E2 does not affect CRP levels, possibly by avoiding a hepatic first-pass effect. The possible cardiovascular protective role of intranasal ...